Connor, Clark & Lunn Investment Management Ltd. Edwards Lifesciences Corp Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 213,700 shares of EW stock, worth $15.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

213,700

Previous 161,804 32.07%

Holding current value

$15.8 Million

Previous $14.9 Million 5.64%

% of portfolio

0.07%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$59.7 - $93.78 $3.1 Million - $4.87 Million	51,896 Added 32.07%	213,700 $14.1 Million
Q2 2024 Aug 09, 2024	BUY	$84.3 - $94.31 $13.2 Million - $14.8 Million	157,043 Added 3298.53%	161,804 $14.9 Million
Q1 2024 May 09, 2024	SELL	$72.54 - $95.56 $19.6 Million - $25.9 Million	-270,756 Reduced 98.27%	4,761 $454,000
Q4 2023 Feb 09, 2024	SELL	$61.71 - $77.76 $15.2 Million - $19.1 Million	-245,912 Reduced 47.16%	275,517 $21 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $23.1 Million - $31.2 Million	333,841 Added 177.97%	521,429 $36.1 Million
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $12.8 Million - $14.9 Million	157,703 Added 527.7%	187,588 $17.7 Million
Q1 2023 May 09, 2023	SELL	$74.26 - $84.51 $21.5 Million - $24.4 Million	-288,880 Reduced 90.62%	29,885 $2.47 Million
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $16.9 Million - $21.6 Million	246,991 Added 344.12%	318,765 $23.8 Million
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $839,844 - $1.09 Million	-10,196 Reduced 12.44%	71,774 $5.93 Million
Q2 2022 Aug 05, 2022	SELL	$86.5 - $128.27 $144,801 - $214,723	-1,674 Reduced 2.0%	81,970 $7.8 Million
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $8.53 Million - $10.7 Million	83,644 New	83,644 $9.85 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $25 Million - $30.7 Million	-235,227 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $2.01 Million - $2.4 Million	-19,536 Reduced 7.67%	235,227 $26.6 Million
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $6.82 Million - $8.52 Million	81,374 Added 46.93%	254,763 $26.4 Million
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $10.7 Million - $12.3 Million	135,836 Added 361.72%	173,389 $14.5 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $1.26 Million - $1.61 Million	-17,622 Reduced 31.94%	37,553 $3.43 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $3.71 Million - $4.82 Million	55,175 New	55,175 $4.4 Million
Q2 2020 Aug 13, 2020	SELL	$57.54 - $76.95 $1.18 Million - $1.58 Million	-20,500 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$52.41 - $81.0 $1.07 Million - $1.66 Million	20,500 New	20,500 $1.29 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Edwards Lifesciences Corp Transaction History